Wilmington, DE, United States of America

Millicent Sullivan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Millicent Sullivan: Innovator in Nucleic Acid Delivery

Introduction

Millicent Sullivan is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. Her innovative work focuses on enhancing the efficiency of delivering genetic materials into cells, which has important implications for medical treatments and therapies.

Latest Patents

Millicent Sullivan holds a patent for her invention titled "Collagen-mimetic peptide mediated delivery of nucleic acid carriers for efficient delivery from collagen." This invention provides a composition designed to deliver polynucleotides into cells using a polyplex. The polyplex consists of the polynucleotide and a polymer, along with a collagen-mimetic peptide (CMP) and collagen fragments. The CMP is bound to both the polyplex and the collagen fragments, facilitating improved delivery methods. The composition has various applications, including methods for enhancing wound healing, promoting cell proliferation, increasing extracellular matrix production, and improving cell migration.

Career Highlights

Millicent Sullivan is affiliated with the University of Delaware, where she continues her research and development in the field of biotechnology. Her work has garnered attention for its potential to revolutionize how genetic materials are delivered in therapeutic contexts. With her innovative approach, she is paving the way for advancements in medical treatments.

Collaborations

Millicent collaborates with notable colleagues, including Kristi Kiick and Morgan Urello. These partnerships enhance her research efforts and contribute to the development of cutting-edge solutions in biotechnology.

Conclusion

Millicent Sullivan's contributions to nucleic acid delivery systems exemplify the impact of innovative thinking in biotechnology. Her patent and ongoing research hold promise for significant advancements in medical therapies and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…